Online Database of Chemicals from Around the World

Hydrocodone
[CAS# 125-29-1]

Suppliers
Alfa Chemistry USA Inquire  
+1 (201) 478-8534
inquiry@alfa-chemistry.com
Chemical distributor since 2012
chemBlink standard supplier since 2012
Alsachim SAS France Inquire  
+33 (368) 240-080
contact@alsachim.com
Chemical manufacturer
BOC Sciences USA Inquire  
+1 (631) 485-4226
info@bocsci.com
Skype Chat
Chemical distributor
chemBlink massive supplier since 2012
Cayman Chemical Company USA Inquire  
+1 (734) 971-3335
sales@caymanchem.com
Chemical manufacturer
Dalton Pharma Services Canada Inquire  
+1 (416) 661-2102
chemist@dalton.com
Chemical manufacturer
International Laboratory Limited USA Inquire  
+1 (650) 278-9963
admin@intlab.org
Chemical manufacturer since 2002
LGC Standards UK Inquire  
+44 (20) 8943-8480
uksales@lgcstandards.com
Chemical manufacturer since 2007
Identification
Name Hydrocodone
Synonyms Dea No. 9193; Ncgc00159317-02; Ncgc00159317-03
Molecular Structure CAS#: 125-29-1, Hydrocodone
Molecular Formula C18H21NO3
Molecular Weight 299.37
CAS Registry Number 125-29-1
EINECS 204-733-9
SMILES [C@@]125C3=C4C[C@H]([C@@H]1CCC([C@@H]2OC3=C(C=C4)OC)=O)N(C)CC5
InChI 1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3,6,11-12,17H,4-5,7-9H2,1-2H3/t11-,12+,17-,18-/m0/s1
InChIKey LLPOLZWFYMWNKH-CMKMFDCUSA-N
Properties
Desity 1.312g/cm3 (Cal.)
Boiling point 461.428°C at 760 mmHg (Cal.)
Flash point 232.864°C (Cal.)
Safety Data
Controlled Substance DEA Drug Code Number: 9193 Details
CSA Schedule: II
Is Narcotics? Yes
References
(1) Kenneth E. Thummel and Danny D. Shen. Peak Time, "Goodman & Gilman's The Pharmacological Basis of Therapeutics", 10/e, Ed. by Joel G. Hardman, Lee E. Limbird and Alfred Goodman Gilman, McGraw-Hill, pp. 1917-2023'Peak-Time' values have been taken from the Table A-II-1 given in Appendix II of the above mentioned reference. These are in hours unless otherwise indicated. Users are requested to go through the comments associated with these values, which have been given as footnotes in the table. Only drugs that had 'Peak-Time' values indicated for them have been provided in the files here. Structures (and values) for Clavulanate (1.3), Enoxaparin (3), Epoetin Alfa (SC: 18, IP:12), Etanercept (SC-SD:72(48-96)), Filgrastim (4-5.8), Heparin (3), Interferon Alfa (IM:3.8,SC:7.3), Interferon Beta (SC:1-8), Lithium (IR:0.5-3, SR:2-6), Mycophenolate (MPA: 1.1-2.2), Prednisolone (1.5+-0.5), Sargramostim (A,SC: 1-3, C,SC:1.5-4) and Streptokinase (0.9+-0.21) have not been provided here. In all, 270 drugs and their 'Peak-Time' values are given in the files here.
(2) Kenneth E. Thummel and Danny D. Shen. Urinary Excretion, "Goodman & Gilman's The Pharmacological Basis of Therapeutics", 10/e, Ed. by Joel G. Hardman, Lee E. Limbird and Alfred Goodman Gilman, McGraw-Hill, pp. 1917-2023Urinary Excretion (%) values have been taken from the Table A-II-1 given in Appendix II of the above mentioned reference. Users are requested to go through the comments associated with these values, which have been given as footnotes in the table. Only drugs that had Urinary Excretion values indicated for them have been provided in the files here. Structures (and values) for Alteplase (t-PA) (Low), Clavulanate (43+-14), Enoxaparin (43), Epoetin alfa (<3), Etanercept (Negligible), Heparin (Negligible), Lithium (95+-15), Mycophenolate (MPA: <1), Prednisolone (26+-9), Rapacuronium (6-22) and Streptokinase (0) have not been provided here. In all, 297 drugs and their Urinary Excretion values (%) are given in the files here.
(3) Kenneth E. Thummel and Danny D. Shen. Peak Concentration, "Goodman & Gilman's The Pharmacological Basis of Therapeutics", 10/e, Ed. by Joel G. Hardman, Lee E. Limbird and Alfred Goodman Gilman, McGraw-Hill, pp. 1917-2023'Peak-Concentrations' values have been taken from the Table A-II-1 given in Appendix II of the above mentioned reference. The units are indicated along with the values. Users are requested to go through the comments associated with these values, which have been given as footnotes in the table. Structures (and values) for Alteplase (t-PA) (973+-133 ng/ml), Clavulanate (2.8 micro g/ml), Enoxaparin (ACLM: 145+-45 ng/ml, BCLM: 414+-87 ng/ml), Epoetin Alfa (SC: 176+-75 U/l, IP: 375+-123 U/l), Etanercept (IV:2.32 micro-g/ml, SC-SD:1.2 micro-g/ml, SC-MD 3 micro-g/ml), Filgrastim (SC: 4 and 49 ng/ml), Heparin (70+-39 ng/ml), Infliximab (118 micro-g/ml), Interferon Alfa (IV: ~13 ng/ml, IM: 2.0 (1.5-2.6) ng/ml, SC: 1.7 (1.2-2.3) ng/ml), Interferon Beta (IV: 1491+-659 IU/ml, SC: 40+-20 IU/ml), Lithium (IR: 1-2 mM, SR: 0.7-1.2 mM), Mycophenolate (MPA: 8-19 micro-g/ml), Prednisolone (458+-150 ng/ml), Rapacuronium (6-20 micro-g/ml), Sargramostim (A, IV: 5ng/ml, A, SC: 1.5 ng/ml, C, IV: 100 ng/ml, C, SC: 10 ng/ml) and Streptokinase (188+-58 IU/ml) have not been provided here. In all, 304 drugs and their 'Peak-Concentration' values are given in the files here.
(4) Kenneth E. Thummel and Danny D. Shen. Clearance , "Goodman & Gilman's The Pharmacological Basis of Therapeutics", 10/e, Ed. by Joel G. Hardman, Lee E. Limbird and Alfred Goodman Gilman, McGraw-Hill, pp. 1917-2023'Clearance' values have been taken from the Table A-II-1 given in Appendix II of the above mentioned reference. These are in (ml/min/kg) units unless otherwise indicated. Users are requested to go through the comments associated with these values, which have been given as footnotes in the table. Only drugs that had 'Clearance' values indicated for them have been provided in the files here. Structures (and values) for Alteplase (t-PA) (10+-4), Clavulanate (3.6+-1.0), Enoxaparin (0.3+-0.1), Epoetin Alfa (0.047+-0.017 (0.047-0.092)), Etanercept (0.02), Filgrastim (0.5-0.7), Heparin (1/(0.65 + 0/0.008D) +- 0.1), Interferon Alfa (2.8+-0.6), Interferon Beta (13+-5), Lithium (0.35+-0.11), Mycophenolate (MM: 120-163, MPA: 2.5+-0.4), Prednisolone (1.0+-0.16), Rapacuronium (7-11), Sargramostim (A: 420 ml/min/(m.m), C:49(15-118) ml/min/(m.m)) and Streptokinase (1.7+-0.7) have not been provided here. In all, 301 drugs and their 'Clearance' values are given in the files here.
Market Analysis Reports
List of Reports Available for Hydrocodone
Related Products
Butabarbital  Phosphorous Acid, Didecyl Phenyl Ester  1-Ethyl-3-[(2-Hydroxy-2,2-Diphenylacetyl...  alpha-Cyclohexyl-alpha-Hydroxy-Benzeneac...  Fenpiverinium Bromide  Methylarginyl-Lysyl-Prolyl-Tryptophyl-Te...  2-Hydroxy-4,6-Dimethoxy-1,3-Benzenedicar...  5-[Bis[(2-Hydroxyphenyl)Methyl]Amino]-2-...  5-[[(2,5-Dihydroxyphenyl)Methyl][(2-Hydr...  5-[[(2,5-Dihydroxyphenyl)Methyl]Amino]-2...  2-Chloro-9-[(4-Methylphenyl)Methyl]-N-Ph...  Synthetic amino-terminal parathyroid hor...  2-[(2,2-Dimethyl-1-Oxopropyl)Amino]-3-Py...  2,5-Dibromostyrene  Strontium Titaniumoxide (Srtio3)  



©  chemBlink. All rights reserved.  Content Disclaimer  |  About chemBlink  |  Contact